ArticleMalaria journal2026
Plasmodium vivax congenital and neonatal malaria with atypical presentation in Western Ethiopia: four cases highlighting diagnostic pitfalls.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital and neonatal malaria (CNM) is under-recognized in Ethiopia and often presents with features that mimic neonatal sepsis. Plasmodium falciparum remains the predominant cause of malaria both nationally and at our facility, while CNM due to Plasmodium vivax is uncommon. Nevertheless, clearer clinical descriptions are needed to support early recognition. The presence of P. vivax, historically neglected in malaria control programmes, introduces additional complexity in the recognition and management of CNM.
methodsWe conducted a descriptive case series of neonates admitted to the neonatal intensive care unit of Aira General Hospital, between June 2024 and September 2025. Clinical presentation, diagnostic workup, treatment, and outcomes were documented for neonates diagnosed with congenital or neonatal malaria.
resultsFour neonates were included two girls with a median age at presentation of 18 days (range 1-21). Fever and poor feeding were each seen in three infants, tachypnea in two; one was afebrile and presented with omphalitis. Two had thrombocytopenia and one anaemia. Plasmodium vivax was confirmed on Giemsa-stained thick/thin smears (parasitaemia + 1 in two cases, + 2 in one, and 3 in one). All received IV artesunate (3 mg/kg) plus empiric antibiotics and were discharged by hospital day 7; no deaths. Maternal malaria was documented in two pregnancies (one vivax, one falciparum), and one infant presented on day 1, consistent with congenital infection. Outpatient follow-up was recorded for one case.
conclusionThis case series underscores the clinical diversity and diagnostic challenges of P. vivax-associated congenital and neonatal malaria in Ethiopia. The findings highlight the need for heightened clinical suspicion in endemic regions, especially where neonatal sepsis is common. The rising incidence of P. vivax relative to P. falciparum calls for renewed attention from clinicians, researchers, and policymakers to strengthen diagnostic capacity, surveillance, and targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.